Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy

Overview of attention for article published in PLOS ONE, February 2011

Altmetric Badge

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 75 Mendeley

Summary Dimensions citations

So far, Dimensions has found 50 publications that cite this research output.

50

The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.

No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]

Article in Neurology and Therapy (October 2023)

Are highly active and aggressive multiple sclerosis the same entity?

Article in Frontiers in Neurology (March 2023)

Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?

Article in Frontiers in Neurology (April 2022)